# BridgeBio Oncology Therapeutics, Inc.: insider transactions

BBOT · Nasdaq · CIK 1869105 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/bbot.md) · [Financials](/companies/bbot/financials.md) · [Filings](/companies/bbot/filings.md) · [Insiders](/companies/bbot/insiders.md)

## All transactions: 2

Non-derivative transactions reported on Forms 4, newest first. Codes P (purchase) and S (sale) are open-market trades. Reported price is as stated on the form, not a market price. Filter with ?type= `open-market`, `purchase`, `sale`.

| Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-21 | [Cobo Marc](/insiders/1816654.md) | Principal Accounting Officer, Officer | Tax withholding (F) | 203 | $2.68 | $544.04 | [Form 4](/filings/0001193125-26-430449.md) |
| 2025-10-10 | [BridgeBio Pharma LLC](/insiders/2076615.md) | 10% owner | Other (J) | 784,720 | not reported | not reported | [Form 4](/filings/0001193125-25-241634.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 24, 2026, 15:06 ET. No prices; not investment advice.